PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $458,000 | -1.1% | 145,354 | -8.6% | 0.01% | +16.7% |
| Q2 2020 | $463,000 | -20.9% | 158,981 | -23.4% | 0.01% | -33.3% |
| Q1 2020 | $585,000 | -22.2% | 207,598 | -10.4% | 0.01% | +50.0% |
| Q4 2019 | $752,000 | +52.8% | 231,800 | +1.8% | 0.01% | +50.0% |
| Q3 2019 | $492,000 | -38.0% | 227,682 | -9.8% | 0.00% | -33.3% |
| Q2 2019 | $793,000 | -39.6% | 252,511 | -28.4% | 0.01% | -33.3% |
| Q1 2019 | $1,312,000 | +34.2% | 352,588 | +4.5% | 0.01% | +12.5% |
| Q4 2018 | $978,000 | +44.5% | 337,366 | +31.1% | 0.01% | +100.0% |
| Q3 2018 | $677,000 | -21.2% | 257,303 | -29.9% | 0.00% | -33.3% |
| Q2 2018 | $859,000 | -19.4% | 367,225 | +1.3% | 0.01% | -25.0% |
| Q1 2018 | $1,066,000 | +22.7% | 362,594 | +14.3% | 0.01% | +33.3% |
| Q4 2017 | $869,000 | -44.4% | 317,145 | -31.2% | 0.01% | -45.5% |
| Q3 2017 | $1,563,000 | +124.6% | 460,946 | +63.7% | 0.01% | +120.0% |
| Q2 2017 | $696,000 | +19.6% | 281,646 | +9.9% | 0.01% | +25.0% |
| Q1 2017 | $582,000 | +22.0% | 256,174 | +13.7% | 0.00% | 0.0% |
| Q4 2016 | $477,000 | -40.4% | 225,218 | -5.8% | 0.00% | -42.9% |
| Q3 2016 | $801,000 | -30.7% | 239,051 | -35.1% | 0.01% | -30.0% |
| Q2 2016 | $1,156,000 | +4.9% | 368,094 | +11.2% | 0.01% | -9.1% |
| Q1 2016 | $1,102,000 | +0.9% | 330,907 | +7.3% | 0.01% | 0.0% |
| Q4 2015 | $1,092,000 | -93.8% | 308,443 | -11.9% | 0.01% | -42.1% |
| Q3 2015 | $17,602,000 | +1061.1% | 349,936 | +48.5% | 0.02% | +46.2% |
| Q2 2015 | $1,516,000 | +41.2% | 235,719 | +54.4% | 0.01% | +44.4% |
| Q1 2015 | $1,074,000 | +109.4% | 152,625 | +129.2% | 0.01% | +125.0% |
| Q4 2014 | $513,000 | -2.5% | 66,582 | -5.4% | 0.00% | 0.0% |
| Q3 2014 | $526,000 | -21.8% | 70,378 | +1.2% | 0.00% | -33.3% |
| Q2 2014 | $673,000 | +19.5% | 69,538 | +2.6% | 0.01% | +20.0% |
| Q1 2014 | $563,000 | +2.2% | 67,766 | +11.9% | 0.01% | -16.7% |
| Q4 2013 | $551,000 | +122.2% | 60,570 | +94.4% | 0.01% | +100.0% |
| Q3 2013 | $248,000 | – | 31,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
| Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
| GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
| Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
| Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
| Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
| RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
| SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |